Multimeric analysis in diagnosis of vWD variants in Indians

Indian Journal of Pathology and Microbiology

Volumn 50, Issue 3, 2007, Pages 636-639

  Gupta, P K ^a   Kumar, Harsh ^a   Saxena, Renu ^b  

^a ARMED FORCES MEDICAL COLLEGE   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Indians; Multimeric analysis; Von Willebrand disease

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 8; RISTOCETIN; THROMBOCYTE FACTOR 3; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR ANTIGEN;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BLEEDING TIME; BLOOD CLOTTING TEST; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT SELECTION; PROTHROMBIN TIME; SCREENING TEST; SKIN BLEEDING; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLEEDING TIME; CHILD; CHILD, PRESCHOOL; FACTOR VIII; FEMALE; HUMANS; INDIA; INFANT; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; PLATELET FACTOR 3; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 34548247620     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84:160-74.
2. Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost 1994; 82:576-84.
3. Schneppenheim R., Thomas KB, Sutor AH. Von Willebrand disease in childhood. Semin Thromb Hemost 1995; 21: 261-75.
4. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalance of von Willebrand's disease. Blood 1987; 69:454-9.
5. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123:893-8.
6. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71:520-3.
7. Sadler J.E. Biochemistry and genetics of von Willebrand Factor. Ann Rev Biochem 1998; 67:395.
8. Dean JA, Blanchette VS, Carcao MD, et al. von Willebrand disease in a pediatric based population - Comparison of type 1 diagnostic criteria and use of the PFA -100 and a von Willebrand factor/Collagen - binding assay. Thromb Haemost 2000; 84: 401-9.
9. Mielke CH, Kaneshiro MM, Maher IA, et al. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34:204-15.
10. th edn. London: Chruchill Livingstone, 2001.
11. Hardisty RM, Hutton RA. Platelet aggregation and the availability of platelet factor 3. Br J Haematol 1966; 12:764-6.
12. Weiss H.J., Hoyer L.W., Rickles F.R. et al. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Inves 1973; 52:2708-16.
13. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII / von / Willebrand factor. Blood 1981; 57:1140-3.
14. Enayat MS, Hill FGH. Analysis of the complexity of the multimeric structure of factor VIII related antigen / von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 1983; 36:915-9.
15. Castaman G, Rodeghiero F. Current management of von Willebrand disease. Drugs 1995; 50:602-14.
16. Tuddenham E.G.D. von Willebrand factor and its disorders: an overview of recent molecular studies. Blood Rev 1989; 3:251-62.
17. Lenk H., Nilsson I.M., Holmberg L., Weissbach G. Frequency of different types of von Willebrand's disease in the GDR. Acta Med Scand 1988; 224:275-80.
18. Hoyer LW, Rizza CR, Tuddenham EG, Carta CA, Armitage H, Rotblat F. von Willebrand factor multimer patterns in von Willebrand's disease. Br J Haematol 1983; 55:493-507.
19. th issue. 2003. Orthopaedic Hospital, 2400S Flower st., Los Angeles, CA. 90007.
20. Ioana C, Nitu - Whalley, Anne Riddell, et al. Identification of Type 2 von Willebrand Disease in Previously Diagnosed Type 1 Patients: a Reappraisal Using Phenotypes, Genotypes and Molecular Modelling. Throm Haemost 2000; 84: 998-1004.
21. Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Italian Association of Hemophilia Centers (AICE). Haemophilia 2002; 8:607-21.
22. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90:2515-21.
23. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med 1983; 309: 816-21.
24. Mazurier C, Gaacher C, Jorieux S, Goudemand M, the Collaborative Group. Biological effect of desmopressin in eight patients with type 2N ("Normandy") von Willebrand disease. Br J Haematol 1994; 88:849-54.